The activation of P38MAPK Signaling Pathway Impedes the Delivery of the Cx43 to the Intercalated Discs During Cardiac...

Area of Science:

• Cardiovascular Biology
• Cellular Signaling
• Molecular Medicine

Background:

• Myocardial ischemia-reperfusion (I/R) injury is a major cause of heart disease mortality.
• Connexin 43 (Cx43) trafficking to intercalated discs (ICDs) is crucial for cardiac function and is affected by I/R.
• Understanding Cx43 downregulation mechanisms post-I/R is vital for therapeutic development.

Purpose of the Study:

• To investigate the molecular mechanisms behind Cx43 downregulation in ICDs following myocardial I/R.
• To explore the role of the P38MAPK signaling pathway and microtubule dynamics in this process.

Main Methods:

• Gene set enrichment analysis (GSEA) to identify activated pathways.
• Western blotting and immunofluorescence to assess protein levels and localization.
• Pharmacological inhibition of P38MAPK signaling using SB203580.

Main Results:

• Myocardial I/R activated the P38MAPK signaling pathway.
• I/R induced microtubule depolymerization, which was attenuated by P38MAPK inhibition.
• SB203580 recovered Cx43 distribution and improved electrophysiological parameters, dependent on microtubule stability.

Conclusions:

• P38MAPK pathway activation leads to microtubule depolymerization after myocardial I/R.
• This microtubule depolymerization is a key mechanism causing Cx43 downregulation in ICDs.
• Targeting P38MAPK and stabilizing microtubules may offer a therapeutic strategy for I/R injury.